Current Opinion in Immunology,
Journal Year:
2024,
Volume and Issue:
91, P. 102487 - 102487
Published: Sept. 21, 2024
A
simple
definition
of
life
is
a
system
that
can
self-replicate
(proliferation)
and
self-sustain
(metabolism).
At
the
cellular
level,
metabolism
has
evolved
to
drive
proliferation,
which
requires
energy
building
blocks
duplicate
biomass
before
division.
T
lymphocytes
(or
cells)
are
required
for
adaptive
immune
responses,
protecting
us
against
invading
malignant
agents
capable
hyper-replication.
To
gain
competitive
advantage
over
these
agents,
activated
cells
their
divide
into
two
daughter
in
as
short
2-6
hours,
considered
fastest
cell
division
among
all
types
vertebrates.
Thus,
primary
task
commit
available
resources
hyperproliferation.
Beyond
that,
cycle
involves
an
ordered
series
fate-determining
events
transition
between
discrete
states.
stages
not
involved
hyperproliferation,
engage
metabolic
programs
more
flexible
sustain
viability
maintenance
sometimes
fine-tuned
support
specific
activities.
Here,
we
focus
on
central
carbon
metabolism,
most
relevant
proliferation.
We
provide
examples
how
changes
may
or
change
fate
further
explore
few
conceptual
frameworks,
such
flexibility,
Goldilocks
Principle,
overflow
effector-signaling
metabolites,
context
transitions.
Cell,
Journal Year:
2024,
Volume and Issue:
187(9), P. 2052 - 2078
Published: April 1, 2024
Adaptive
immunity
provides
protection
against
infectious
and
malignant
diseases.
These
effects
are
mediated
by
lymphocytes
that
sense
respond
with
targeted
precision
to
perturbations
induced
pathogens
tissue
damage.
Here,
we
review
key
principles
underlying
adaptive
orchestrated
distinct
T
cell
B
populations
their
extensions
disease
therapies.
We
discuss
the
intracellular
intercellular
processes
shaping
antigen
specificity
recognition
in
immune
activation
lymphocyte
functions
mediating
effector
memory
responses.
also
describe
how
balance
protective
autoimmunity
immunopathology,
including
during
tolerance,
response
chronic
stimulation,
adaptation
non-lymphoid
tissues
coordinating
homeostasis.
Finally,
extracellular
signals
cell-intrinsic
programs
underpinning
conclude
summarizing
advances
vaccination
engineering
responses
for
therapeutic
interventions.
A
deeper
understanding
of
these
holds
promise
uncovering
new
means
improve
human
health.
Science Immunology,
Journal Year:
2025,
Volume and Issue:
10(103)
Published: Jan. 17, 2025
Immune
responses
against
cancer
are
dominated
by
T
cell
exhaustion
and
dysfunction.
Recent
advances
have
underscored
the
critical
role
of
early
priming
interactions
in
establishing
fates.
In
this
review,
we
explore
importance
dendritic
(DC)
signals
specifying
CD8+
fates
cancer,
drawing
on
insights
from
acute
chronic
viral
infection
models.
We
highlight
DCs
lymph
nodes
tumors
maintaining
stem-like
cells,
which
for
durable
antitumor
immune
responses.
Understanding
how
determined
will
enable
rational
design
immunotherapies,
particularly
therapeutic
vaccines,
that
can
modulate
DC-T
to
generate
beneficial
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 135 - 135
Published: Jan. 28, 2025
T
cell
epitope-based
vaccines
are
designed
to
elicit
long-lived
pathogen-specific
memory
cells
that
can
quickly
activate
protective
effector
functions
in
response
subsequent
infections.
These
have
the
potential
provide
sustained
protection
against
mutated
variants,
such
as
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
which
increasingly
capable
of
evading
neutralizing
antibodies.
Recent
advancements
epitope
discovery,
receptor
analysis,
and
bioinformatics
enabled
precise
selection
epitopes
sophisticated
design
vaccines.
This
review
outlines
development
process
for
We
summarize
current
progress
discovery
technologies,
highlighting
advantages
disadvantages
each
method.
also
examine
optimization
vaccines,
particularly
through
tools.
Additionally,
we
discuss
challenges
validating
accurate
processing
presentation
individual
establishing
suitable
rodent
models
evaluate
vaccine
immunogenicity
efficacy.
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(52)
Published: Dec. 18, 2024
Inhibiting
indoleamine
2,3
dioxygenase
(IDO)
for
anticancer
therapy
has
garnered
significant
attention
in
recent
years.
However,
current
IDO
inhibitors
face
challenges
which
limit
their
clinical
application.
Here,
we
genetically
engineered
a
high
tryptophan-expressing
Clostridium
butyricum
(L-Trp
CB)
strain
that
can
colonize
tumors
strictly
following
systemic
administration.
We
revealed
butyrate
produced
by
L-Trp
CB
inhibit
activity,
preventing
tryptophan
catabolism
and
kynurenine
accumulation
tumors.
In
addition,
the
large
released
provide
discrete
signals
support
CD8+
T
cell
activation
energy
metabolism
within
tumor
microenvironment.
observed
significantly
restored
proportion
function
of
cells,
leading
to
delayed
growth
both
mouse
rabbit
multiple
models
with
limited
side
effects.
here
synthetic
biology
treatment
strategy
enhanced
immunotherapy
inhibiting
activity
reprogramming
response
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 24, 2025
Summary
/
Abstract
To
maintain
lineage-specific
functions,
cells
must
acquire
and
allocate
nutrients
across
diverse
cellular
processes,
even
in
metabolically-dysregulated
environments.
The
mechanisms
allowing
CD8+
T
to
immune
function
perturbed
environments
are
poorly
understood.
We
find
that
adapt
nutrient
stresses
over
time,
reconfiguring
gene-regulatory
metabolic
networks
license
functional
recovery.
Under
acute
stress,
reorient
translational
programming,
limiting
demand
while
prioritizing
stress-sensitive
transcriptional
responses.
Within
these
responses,
the
transcription
factors
ATF4
CEBPG
jointly
establish
an
adaptive
program,
promoting
amino
acid
synthesis
uptake
maintaining
mitochondrial
anaplerosis.
Despite
diminished
energetic
capacity
under
environmental
this
program
prevents
failure
of
central
carbon
metabolism,
mitigating
stress
amplification
dysfunction
potentiate
anti-tumor
immunity.
Altogether,
we
demonstrate
biosynthetic
plasticity
via
reprioritization
confers
resilience
unfavorable
environments,
offering
novel
strategies
enhance
immunotherapies.